600 patients66,869 observations120 daysLIVE

Patient P-01321

Synthetic patientNBL-101 · Day 92 · 45–54 · F · baseline S12Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Deteriorating
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
44%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S12
  2. Day 81 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 82 GI-04 recommendedGI Support Protocol GI-04
  4. Day 83 Patient acceptedStarted GI-04 in the companion
  5. Day 91 GI symptom burden −24% vs expectedGI Support Protocol GI-04
  6. Day 97 Tolerance state changedUnstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 81.

Primary contributors, last 14 days
  • Nutritional resilience-11
  • Toxicity+9
  • GI instability+6
  • Inflammatory activity+5
  • Treatment adherence-2

What helped?

  • GI Support Protocol GI-04Day 82
    Result: symptom burden −24%
LIFE OS recommendation
Dietary Support Protocol NP-02
65%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 100% showed improvement
  • median effect visible after 10 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden
Companion
40.7/100
worsening · +19.0 vs previous 14 d
Toxicity
Blood
41/100
worsening · +16.4 vs previous 14 d
Sleep quality
Wearable
27.1/100
worsening · -9.7 vs previous 14 d
Energy level
Daily log
3.8/10
worsening · -1.8 vs previous 14 d
Stress level
Daily log
4.8/10
worsening · +1.3 vs previous 14 d
Steps
Wearable
7,089
worsening · -1,408 vs previous 14 d
Adherence
Companion
83.6 %
stable · -1.3 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards failing · 45 from the failing basin, 42 from restoration.

Would help
  • SC-12 Supportive Compound
    87% improved among 30 similar · onset 6 d · confidence 53%
  • NP-02 Dietary Support Protocol
    76% improved among 29 similar · onset 10 d · confidence 53%
  • DT-01 Dosing / Timing Recommendation
    67% improved among 6 similar · onset 5 d · confidence 53%
Would not help
  • Keep fat low
    GI +2.8 next day on high-intake days · n 23
  • Keep histamine low
    GI +2 next day on high-intake days · n 23
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Dietary fat load
    +2.8detractor · 95%
  • Histamine load
    +2detractor · 73%
  • Simple carbohydrates
    -1.8no signal · 55%
  • Insoluble fibre
    -1.5no signal · 50%
  • Alcohol
    -0.8no signal · 20%
  • Spicy / capsaicin
    -0.7no signal · 17%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Butyrate / short-chain fatty acid production 80
    • MicrobiomeButyrate capacity 44/100
    • MicrobiomeF. prausnitzii depleted
    • Daily logFibre intake low in recent food logs
  • Mucosal barrier integrity 70
    • DNAFUT2 non-secretor lowers mucosal fucosylation
    • MicrobiomeAkkermansia low → thinner mucus layer
    • WearableSleep 5.3 h, below personal baseline
  • Inflammatory signalling 45
    • MicrobiomeBacteroides fragilis expansion
    • BloodInflammatory load index 48
  • Drug metabolism and exposure 20
    • BloodToxicity index 41
  • Autonomic recovery 20
    • WearableShort sleep window
DNA
Fictional pharmacogenomic panel
  • FUT2 rs601338 AA (non-secretor)
    Reduced mucosal fucosylation
  • CYP2D6 Intermediate metabolizer
    Expected exposure
  • MTHFR C677T
    Reduced folate turnover
Microbiome
Shannon diversity 3 · butyrate capacity 44/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisHigh
  • Bifidobacterium longumLow
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
61 ms
Sleep
5.7 h
Steps
6,832
Resting HR
65 bpm
Daily log: GI score 41, nutritional resilience 43, adherence 84.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • Keep the current walking rhythm
  • Protect a 7.5-hour sleep window; screens off 30 minutes before
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: oral nutrition supplement with lunch

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0144538%S1358
P-0137536%S1664
P-0148136%S0354
P-0188936%S1662
P-0131735%S1965
P-0137135%S06CR-01improved63
P-0147835%S1853
P-0149835%S0256
P-0154835%S1658
P-0156235%S04HY-01no change49
P-0157135%S13SC-12improved57
P-0164235%S1152